NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board
GlobeNewswire News Room· 2024-11-26 20:30
DUBLIN and GARDEN CITY, N.Y., Nov. 26, 2024 (GLOBE NEWSWIRE) -- NeuroNOS, a pioneering biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and other complex neurological conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is proud to announce the appointment of Professor Roger D. Kornberg, to its Scientific Advisory Board (SAB). This appointment marks a key milestone in NeuroNOS’s commitment to advancing scientific innovation and improving the ...
Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
GlobeNewswire News Room· 2024-11-26 20:30
Resubmission addresses questions raised in January 2024 Complete Response Letter F8 formulation intended to replace EGRIFTA SV® with simplified dosing for the treatment of excess abdominal fat in adults with HIV and lipodystrophy MONTREAL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the resubmission of its suppleme ...
Cognition Therapeutics Announces all Participants have Completed their Final Visits in the Phase 2 SHIMMER Study of CT1812 in Dementia with Lewy Bodies
GlobeNewswire News Room· 2024-11-26 20:30
– Topline results in second dementia indication expected to be reported in December 2024 – PURCHASE, N.Y., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the last patient has completed their final clinic visit in the Phase 2 SHIMMER study of CT1812 in patients with mild-to-moderate dementia with Lewy bodies (DLB). The Company anticipates that topline results will be available in ...
Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference
Prnewswire· 2024-11-26 20:30
BOSTON, Nov. 26, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced that Joseph J. Ferra, President and Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, at 8:30 a.m. ET.A live w ...
Canopy Growth Announces Mr. Luc Mongeau As The Company's Next CEO
Prnewswire· 2024-11-26 20:30
A seasoned executive with broad CPG experience, Mr. Mongeau has most recently served as the CEO of North America's leading e-commerce provider for residential and commercial furniture. He has previously held the role of President for Weston Foods, one of North America's premier bakeries, as well as President of Mars Petcare North America, the core business unit of the world's largest pet care company. Since joining the Board as an observer in early 2023 and as a Board member in February 2024, Mr. Mongeau ha ...
Lifeway Provides Additional Information Regarding Reasons for Rejecting Danone's Revised Proposal
Prnewswire· 2024-11-26 20:30
MORTON GROVE, Ill., Nov. 26, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) (the "Company" or "Lifeway"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided additional information regarding the reasons that its Board of Directors rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.The Board determined ...
Kelly Announces Completion of CFO Transition, Participation in Sidoti Virtual Investor Conference
GlobeNewswire News Room· 2024-11-26 20:30
TROY, Mich., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced the completion of its previously announced CFO transition. Troy Anderson, who joined Kelly in October 2024, will succeed Olivier Thirot as the Company’s chief financial officer, effective December 2, 2024. Thirot will retire as an officer of Kelly, while continuing to serve the Company as a strategic advisor. “I’m grateful to serve as Kelly’s chief financial offi ...
The TJX Companies: I Am Waiting For TJX To Accelerate Its Growth
Seeking Alpha· 2024-11-26 20:29
Following my coverage on The TJX Companies (NYSE: TJX ) in Sep'24, in which I recommended a hold rating as the share price has already rallied to a level where I felt the upside wasI take a fundamentals-based approach to value investing.I disagree with the common misconception held by many investors that low multiple stocks must be cheap. I look for companies that offer the best long-term durability at the most affordable prices. Consequently, I have a propensity to be drawn to companies with steady long-te ...
Intel awarded $7.9 billion from the CHIPS Act ahead of Trump's second term
Business Insider· 2024-11-26 20:26
文章核心观点 - 英特尔公司从拜登政府获得79亿美元联邦补助,作为CHIPS法案的一部分,用于在美国提升半导体生产 [1][2][3] 补助金额 - 英特尔获得的补助金额为79亿美元,比拜登政府最初宣布的85亿美元少6亿美元 [2] - 英特尔还额外获得了30亿美元的补助,用于为军方生产芯片 [2] 补助发放时间 - 英特尔预计在今年年底前至少获得10亿美元的补助 [3] 补助用途 - 补助将帮助英特尔在美国提升半导体生产,预计到本十年末将投资近900亿美元 [4] 政府和公司声明 - 美国商务部长吉娜·雷蒙多表示,英特尔在亚利桑那州、新墨西哥州、俄亥俄州和俄勒冈州的投资将“超级加速美国创新”,并认为英特尔在半导体行业的“复兴”中扮演重要角色 [4] - 英特尔CEO帕特·基辛格表示,两党对恢复美国技术和制造业领导地位的强烈支持正在推动历史性投资,这对国家的长期经济增长和国家安全至关重要 [5] 公司现状 - 英特尔股价今年下跌了近50%,公司面临巨额亏损和一系列挑战,包括裁员 [5] 潜在收购 - 《华尔街日报》9月报道,高通对收购英特尔感兴趣,但由于一些复杂问题,收购兴趣已冷却 [6]
New Strong Buy Stocks for November 26th
ZACKS· 2024-11-26 20:26
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:ZIM Integrated Shipping Services Ltd. (ZIM) : This container shipping provider has seen the Zacks Consensus Estimate for its current year earnings increasing 41.7% over the last 60 days.monday.com Ltd. (MNDY) : This software development company has seen the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.Rush Street Interactive, Inc. (RSI) : This online casino and sports betting company has ...